Hostname: page-component-6bb9c88b65-9c7xm Total loading time: 0 Render date: 2025-07-22T05:37:58.061Z Has data issue: false hasContentIssue false
Accepted manuscript

Should Glutamatergic Modulators Be Considered Preferential Treatments for Adults with Major Depressive Disorder and A Reported History of Trauma? Conceptual and Clinical Implications

Published online by Cambridge University Press:  26 May 2025

Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Perspective
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
© The Author(s), 2025. Published by Cambridge University Press